BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies
BioNTech has reported a new technology that could overcome some of the most challenging issues…
BioNTech has reported a new technology that could overcome some of the most challenging issues…
Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal…
Meet the founder of three hot British biotechs developing antibody-related technologies. Despite his interest in…
Abcam has paid US-based AxioMx a final €4.5M milestone based on performance, completing an acquisition…
The UK pharma's antibody, tralokinumab, has failed to meet its primary endpoint in Phase III…
Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop…
Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic's APN311 in the…
As immunotherapies are moving from large academic centers to clinics across the world, doctors are…
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis.…
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
Janssen and Genmab will not proceed to evaluate daratumumab as a treatment for non-Hodgkin's lymphoma since it…
After Praluent, Sanofi and Regeneron have now scored their next drug approval with dupilumab, an antibody for the…